Patents by Inventor Mingxia Chen

Mingxia Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12552747
    Abstract: The present invention discloses an amino acid derivative containing a non-steroidal anti-inflammatory drug structure and a preparation method and application thereof. The structural formula of the derivative is as represented by formula I. The novel compound has a broad-spectrum anti-tumor effect, can prolong the survival period of tumor patients, and improve the quality of life of tumor patients.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: February 17, 2026
    Assignee: JIANGSU PROTELIGHT PHARMACEUTICAL & BIOTECHNOLOGY CO., LTD.
    Inventors: Yuxin Chen, Mingxia Chen, Ying Lv, Gang Dong, Xiaoxue Huang
  • Publication number: 20240075096
    Abstract: An antimicrobial peptide composition comprising an antimicrobial peptide, at least one stabilizer, and a buffer system, the mass concentration of the antimicrobial peptide in the composition being 0.1‰ to 10‰; and the buffer system being a phosphate buffer system or an acetate buffer system; the amino acid sequence of the antimicrobial peptide being: KWKSFLKTFaAbKTVLHTALKAISS. The antimicrobial peptide composition is a broad-spectrum anti-infective drug suitable for various primary skin infections caused by pathogenic bacteria, especially drug-resistant bacteria, and secondary skin infections such as an eczema co-infection and an ulcer co-infection, including persistent infectious diseases such as diabetic foot, burn wound infections, and decubitus ulcer infections, and the composition has broad application prospects.
    Type: Application
    Filed: January 19, 2021
    Publication date: March 7, 2024
    Applicant: JIANGSU PROTELIGHT PHARMACEUTICAL & BIOTECHNOLOGY CO., LTD
    Inventors: Yuxin CHEN, Mingxia CHEN, Wenxue CHEN, Xiaoxue HUANG
  • Publication number: 20230167059
    Abstract: The present invention discloses an amino acid derivative containing a non-steroidal anti-inflammatory drug structure and a preparation method and application thereof. The structural formula of the derivative is as represented by formula I. The novel compound has a broad-spectrum anti-tumor effect, can prolong the survival period of tumor patients, and improve the quality of life of tumor patients.
    Type: Application
    Filed: May 7, 2021
    Publication date: June 1, 2023
    Inventors: Yuxin CHEN, Mingxia CHEN, Ying LV, Gang DOGN, Xiaoxue HUANG
  • Patent number: 9273095
    Abstract: Disclosed are an antibiotic peptide and the like, having an amino acid sequence of Ac-Phe-Lys-Lys-Leu-Lys-Lys-Leu-Phe-Ser-Lys-Leu-Trp-Asn-Trp-Lys-NH2 (SEQ ID No:2). Also disclosed are a method of preparing the antibiotic peptide and the like, and the application thereof. The antibiotic peptide and the like synthesized by the solid phase synthetic technology according to the present invention can be used as a formulation against microbial infection and as alternate or adjuvant medicaments of antibiotics in the prior art.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: March 1, 2016
    Assignee: Jiangsu Protelight Pharmaceutical & Biotechnology Co., Ltd.
    Inventors: Yuxin Chen, Mingxia Chen, Yibing Huang, Yang Li, Yong Wang, Lili Qu, Wenren Wang
  • Publication number: 20140329739
    Abstract: Disclosed are an antibiotic peptide and the like, having an amino acid sequence of Ac-Phe-Lys-Lys-Leu-Lys-Lys-Leu-Phe-Ser-Lys-Leu-Trp-Asn-Trp-Lys-NH2 (SEQ ID No:1). Also disclosed are a method of preparing the antibiotic peptide and the like, and the application thereof. The antibiotic peptide and the like synthesized by the solid phase synthetic technology according to the present invention can be used as a formulation against microbial infection and as alternate or adjuvant medicaments of antibiotics in the prior art.
    Type: Application
    Filed: January 17, 2012
    Publication date: November 6, 2014
    Applicant: JIANGSU PROTELIGHT PHARMACEUTICAL & BIOTECHNOLOGY CO., LTD.
    Inventors: Yuxin Chen, Mingxia Chen, Yibing Huang, Yang Li, Yong Wang, Lili Qu, Wenren Wang
  • Publication number: 20100048644
    Abstract: Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder. The lower urinary tract disorder is selected from the group consisting of benign prostate hyperplasia, lower urinary tract syndrome or overactive bladder, especially the lower urinary tract disorder accompanying with hypertension. Amlodipine is any one selected from the group consisting of amlodipine, amlodipine active metabolite, levoamlodipine, pharmaceutically acceptable precursor of amlodipine, or pharmaceutically acceptable salts of amlodipine, amlodipine active metabolite, levoamlodipine, or pharmaceutically acceptable precursor of amlodipine. The pharmaceutical dose of amlodipine is in the range of 1-10 mg. The invention belongs to the field of pharmacy.
    Type: Application
    Filed: October 25, 2007
    Publication date: February 25, 2010
    Applicants: BEIJING HUAANFO BIOMEDICAL RESEARCH CENTRE INC., ANHUI MEDICAL UNIVERSITY BIOMEDICAL INSTITUTE
    Inventors: Xiping Xu, Houxun Xing, Xianhui Qin, Haipeng Liu, Mingxia Chen, Duo Yu, Yan Wang, Guangliang Chen